Date 12.05.2025
Syncom Formulations
Timeframe : Day Chart
Remarks ::
Wait for the price to breakout from ichimoku cloud & 200 exponential moving average
Potential upside from breakout is 20%
About ::
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered
Some Areas Of Concern ::
Stock is trading at 4.96 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 6.60% over past five years.
Company has a low return on equity of 8.77% over last 3 years.
Dividend payout has been low at 4.36% of profits over last 3 years
Regards,
Ankur
Syncom Formulations
Timeframe : Day Chart
Remarks ::
Wait for the price to breakout from ichimoku cloud & 200 exponential moving average
Potential upside from breakout is 20%
About ::
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered
Some Areas Of Concern ::
Stock is trading at 4.96 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 6.60% over past five years.
Company has a low return on equity of 8.77% over last 3 years.
Dividend payout has been low at 4.36% of profits over last 3 years
Regards,
Ankur
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.